Palmoplantar pustulosis confirmed as orphan disease

Palmoplantar pustulosis confirmed as orphan disease

(HealthDay)—Co-occurring psoriasis is common among patients with palmoplantar pustulosis (PPP), according to a study published in the November issue of the British Journal of Dermatology.

Yuki M.F. Andersen, from the University of Copenhagen in Hellerup, Denmark, and colleagues used administrative health care registries and insurance databases from the United States, Denmark, and Germany to identify patients with PPP and their use of antipsoriatic medication.

The researchers identified 1,435 U.S. patients, 751 Danish patients, and 1,832 German patients with PPP; estimated one-year prevalences were 0.009, 0.005, and 0.08 percent, respectively. Between 14.2 and 61.3 percent of patients with PPP had plaque , and there was an overall higher prevalence of psoriatic arthritis among patients with co-occurring psoriasis. Similarly, medication use was more common in patients with PPP with co-occurring psoriasis, especially use of biologic therapies.

"We found that PPP had very low prevalence rates (<0.1 percent), confirming it as an orphan disease," the authors write. "This study provides detailed information on the demographics and characteristics of this understudied patient population and adds to our understanding of the disease burden of PPP with or without co-occurring plaque psoriasis."

Several authors disclosed financial ties to pharmaceutical companies, including Eli Lilly, which funded the study.

Explore further

Abdominal obesity may raise risk for psoriasis

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: British Journal of Dermatology

Copyright © 2019 HealthDay. All rights reserved.

Citation: Palmoplantar pustulosis confirmed as orphan disease (2019, December 3) retrieved 25 November 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments